Mahajan Vinay S, Demissie Ezana, Mattoo Hamid, Viswanadham Vinay, Varki Ajit, Morris Robert, Pillai Shiv
Ragon Institute of MGH, MIT and Harvard, 400 Technology Square, Cambridge, MA 02139, USA.
Departments of Medicine and Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Cell Rep. 2016 May 31;15(9):1901-9. doi: 10.1016/j.celrep.2016.04.080. Epub 2016 May 19.
We describe a homozygous copy-number variant that disrupts the function of Dock2 in a commercially available C57BL/6 mouse strain that is widely used for backcrossing. This Dock2 allele was presumed to have spontaneously arisen in a colony of Irf5 knockout mice. We discovered that this allele has actually been inadvertently backcrossed into multiple mutant mouse lines, including two engineered to be deficient in Siae and Cmah. This particular commercially obtained subline of C57BL/6 mice also exhibits several striking immune phenotypes that have been previously described in the context of Dock2 deficiency. Inadvertent backcrossing of a number of gene-targeted mice into this background has complicated the interpretation of several immunological studies. In light of these findings, published studies involving immune or hematopoietic phenotypes in which these C57BL/6 mice have been used as controls, as experimental animals, or for backcrossing will need to be reinterpreted.
我们描述了一种纯合拷贝数变异,它破坏了广泛用于回交的市售C57BL/6小鼠品系中Dock2的功能。这个Dock2等位基因被推测是在Irf5基因敲除小鼠群体中自发产生的。我们发现这个等位基因实际上已被无意中回交到多个突变小鼠品系中,包括两个经基因工程改造而缺乏Siae和Cmah的品系。这个从商业途径获得的特定C57BL/6小鼠亚系还表现出几种先前在Dock2缺陷背景下已被描述的显著免疫表型。许多基因靶向小鼠无意中回交到这个背景中,使得一些免疫学研究的解释变得复杂。鉴于这些发现,涉及免疫或造血表型且将这些C57BL/6小鼠用作对照、实验动物或用于回交的已发表研究需要重新解读。